GEMINI (GEMI) is highlighted as a potentially undervalued prediction market play, currently valued at $1.5B with a 13% short interest, compared to Polymarket's $9B valuation. Its recent US license for prediction markets could position it for significant growth in the category. This suggests a potential long opportunity for GEMI given its lower valuation and new licensing advantage.